ImpoPharma Overview
- Year Founded
-
1996

- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
ImpoPharma General Information
Description
Provider of drug product formulation and process development services to the pharmaceutical industry specializing in nasal and pulmonary drug delivery systems. The company services include formulation development, analytical development, production process development, manufacturing of stability and clinical batches and other services, enabling people to get dry powder inhalers, metered nasal sprays, metered sublingual sprays, inject-able products, ophthalmic products and oral products.
Contact Information
Website
www.impopharma.comCorporate Office
- 255 Spinnaker Way
- Unit 6
- Concord, Ontario L4K 4J1
- Canada
Corporate Office
- 255 Spinnaker Way
- Unit 6
- Concord, Ontario L4K 4J1
- Canada
ImpoPharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
ImpoPharma Comparisons
Industry
Financing
Details
ImpoPharma Competitors (25)
One of ImpoPharma’s 25 competitors is Cambrex, a Private Equity-Backed company based in East Rutherford, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cambrex | Private Equity-Backed | East Rutherford, NJ | ||||
Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
IriSys (Pharmaceuticals) | Formerly VC-backed | San Diego, CA | ||||
Ascendia Pharmaceuticals | Private Equity-Backed | North Brunswick, NJ | ||||
Center for Breakthrough Medicines | Corporate Backed or Acquired | King of Prussia, PA |
ImpoPharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
ImpoPharma FAQs
-
When was ImpoPharma founded?
ImpoPharma was founded in 1996.
-
Where is ImpoPharma headquartered?
ImpoPharma is headquartered in Concord, Canada.
-
What industry is ImpoPharma in?
ImpoPharma’s primary industry is Drug Discovery.
-
Is ImpoPharma a private or public company?
ImpoPharma is a Private company.
-
What is ImpoPharma’s current revenue?
The current revenue for ImpoPharma is
. -
How much funding has ImpoPharma raised over time?
ImpoPharma has raised $7M.
-
Who are ImpoPharma’s investors?
Genesys Capital, Signet Healthcare Partners, and Venrock have invested in ImpoPharma.
-
Who are ImpoPharma’s competitors?
Cambrex, Dalton Pharma Services, IriSys (Pharmaceuticals), Ascendia Pharmaceuticals, and Center for Breakthrough Medicines are some of the 25 competitors of ImpoPharma.
-
When was ImpoPharma acquired?
ImpoPharma was acquired on 07-Jan-2020.
-
Who acquired ImpoPharma?
ImpoPharma was acquired by Rubicon Research.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »